Immutable evidence record · ticker

NervGen Pharma Corp. (NGEN)

Published as observed on 16 August 2026 at 01:25 BST.

NervGen Pharma Corp. has a balanced company news read. Its latest completed weekly trend is negative.

As of
16 Aug 2026, 01:25
Scope
company and instrument
Evidence
6 items
Independent sources
2
Country
United States
Sector
Healthcare
Previous read
49.000
Change

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, NervGen Pharma Corp. (NGEN), 2026-08-16, https://sharemaestro.com/evidence/5e3d33b5-790d-4168-aab7-10ebe6b16b43/
Record checksum 3a375b25390dd15c15f6b14c143dc8f195e47bfe2b2c4831be9b54dcbb98eaa8

Evidence context